Literature DB >> 20854022

Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates.

Nuria Busquets1, F Xavier, Raquel Martín-Folgar, Gema Lorenzo, Iván Galindo-Cardiel, Bernat Pérez del Val, Raquel Rivas, Javier Iglesias, Fernando Rodríguez, David Solanes, Mariano Domingo, Alejandro Brun.   

Abstract

The increasing interest in Rift Valley fever virus (RVFV) and its potential impact on naive animal populations deserve revisiting experimental reproduction of RVFV infection, particularly in those animal breeds for which no data about their susceptibility to RVFV infection have ever been recorded. In this study we show the susceptibility of 9-10 weeks old European sheep (Ripollesa breed) to RVFV infection, showing a mild, subacute form of disease. Four different viral isolates efficiently replicated in vivo after subcutaneous experimental inoculation, and consistent viral loads in blood and virus shedding (variable in length depending on the RVFV isolate used) were detected, showing horizontal transmission to a noninfected, sentinel lamb. RVFV infection caused transient pyrexia in adult lambs and no other clinical symptoms were observed, with the exception of corneal opacity ("blue eye") found in 3 out of 16 subcutaneously inoculated sheep. In conclusion, adult sheep from this European breed are readily infected with RVFV without apparent clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20854022     DOI: 10.1089/vbz.2009.0205

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  19 in total

1.  The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice.

Authors:  S Tokuda; T Z Do Valle; L Batista; D Simon-Chazottes; L Guillemot; M Bouloy; M Flamand; X Montagutelli; J-J Panthier
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

2.  Assessment of the control measures of the category A diseases of Animal Health Law: Rift Valley Fever.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Helen Clare Roberts; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Simon Gubbins; Alessandro Broglia; Inma Aznar; Yves Van der Stede
Journal:  EFSA J       Date:  2022-01-19

3.  Quantitative analysis of particles, genomes and infectious particles in supernatants of haemorrhagic fever virus cell cultures.

Authors:  Manfred Weidmann; Amadou A Sall; Jean-Claude Manuguerra; Lamine Koivogui; Aime Adjami; Faye Fatou Traoré; Kjell-Olof Hedlund; Gunnel Lindegren; Ali Mirazimi
Journal:  Virol J       Date:  2011-02-24       Impact factor: 4.099

Review 4.  The pathogenesis of Rift Valley fever.

Authors:  Tetsuro Ikegami; Shinji Makino
Journal:  Viruses       Date:  2011-05       Impact factor: 5.048

5.  Innate immune response to Rift Valley fever virus in goats.

Authors:  Charles K Nfon; Peter Marszal; Shunzhen Zhang; Hana M Weingartl
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

6.  Co-housing of Rift Valley Fever Virus Infected Lambs with Immunocompetent or Immunosuppressed Lambs Does Not Result in Virus Transmission.

Authors:  Paul J Wichgers Schreur; Lucien van Keulen; Jet Kant; Nadia Oreshkova; Rob J M Moormann; Jeroen Kortekaas
Journal:  Front Microbiol       Date:  2016-03-07       Impact factor: 5.640

7.  Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination.

Authors:  Gema Lorenzo; Elena López-Gil; Javier Ortego; Alejandro Brun
Journal:  Vet Res       Date:  2018-02-21       Impact factor: 3.683

8.  A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting.

Authors:  Tiphany Chrun; Sandra Lacôte; Céline Urien; Luc Jouneau; Céline Barc; Edwige Bouguyon; Vanessa Contreras; Audrey Ferrier-Rembert; Christophe N Peyrefitte; Nuria Busquets; Enric Vidal; Joan Pujols; Philippe Marianneau; Isabelle Schwartz-Cornil
Journal:  NPJ Vaccines       Date:  2018-04-20       Impact factor: 7.344

9.  International external quality assessment of molecular detection of Rift Valley fever virus.

Authors:  Camille Escadafal; Janusz T Paweska; Antoinette Grobbelaar; Chantel le Roux; Michèle Bouloy; Pranav Patel; Anette Teichmann; Oliver Donoso-Mantke; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2013-05-23

10.  Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever.

Authors:  George M Warimwe; Joseph Gesharisha; B Veronica Carr; Simeon Otieno; Kennedy Otingah; Danny Wright; Bryan Charleston; Edward Okoth; Lopez-Gil Elena; Gema Lorenzo; El-Behiry Ayman; Naif K Alharbi; Musaad A Al-dubaib; Alejandro Brun; Sarah C Gilbert; Vishvanath Nene; Adrian V S Hill
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.